Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.

Prime ME, Andersen OA, Barker JJ, Brooks MA, Cheng RK, Toogood-Johnson I, Courtney SM, Brookfield FA, Yarnold CJ, Marston RW, Johnson PD, Johnsen SF, Palfrey JJ, Vaidya D, Erfan S, Ichihara O, Felicet

J Med Chem. 2012 Feb 9;55(3):1021-46. doi: 10.1021/jm201310y.

0

0

0

PUBMED

Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.

Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, Maiti P, Frautschy SA, Zeitlin S, Levine MS, Chesselet MF.

Mol Neurodegener. 2012 Apr 4;7:12. doi: 10.1186/1750-1326-7-12.

0

0

0

PUBMED

Putting proteins in their place: palmitoylation in Huntington disease and other neuropsychiatric diseases.

Young FB, Butland SL, Sanders SS, Sutton LM, Hayden MR.

Prog Neurobiol. 2012 May;97(2):220-38. doi: 10.1016/j.pneurobio.2011.11.002. Review.

0

0

0

PUBMED

Measures of growth in children at risk for Huntington disease.

Lee JK, Mathews K, Schlaggar B, Perlmutter J, Paulsen JS, Epping E, Burmeister L, Nopoulos P.

Neurology. 2012 Aug 14;79(7):668-74. doi: 10.1212/WNL.0b013e3182648b65.

0

0

0

PUBMED

Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease.

Sarantos MR, Papanikolaou T, Ellerby LM, Hughes RE.

J Huntingtons Dis. 2012;1(2):195-210. doi: 10.3233/JHD-120033.

0

0

0

PUBMED

Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease.

Tang B, Becanovic K, Desplats PA, Spencer B, Hill AM, Connolly C, Masliah E, Leavitt BR, Thomas EA.

Hum Mol Genet. 2012 Jul 15;21(14):3097-111. doi: 10.1093/hmg/dds132.

0

0

0

PUBMED

A Chinese pedigree with an individual homozygous for CAG repeats of Huntington's disease.

Shi SS, Lin Y, Zhao GX, Gan SR, Wu ZY.

Psychiatr Genet. 2012 Feb;22(1):53-4. doi: 10.1097/YPG.0b013e328347c203. No abstract available.

0

0

0

PUBMED

Age, CAG repeat length, and clinical progression in Huntington's disease.

Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis RL, Ross CA.

Mov Disord. 2012 Feb;27(2):272-6. doi: 10.1002/mds.24024.

0

0

0

PUBMED

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.

Ramos EM, Latourelle JC, Lee JH, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, Mc

Hum Genet. 2012 Dec;131(12):1833-40. doi: 10.1007/s00439-012-1205-z.

0

0

0

PUBMED

Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT.

Ha AD, Beck CA, Jankovic J.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-64-287-4. doi: 10.7916/D8FF3R2P.

0

0

0

PUBMED

Abnormal response to cortical activation in early stages of Huntington disease.

Mochel F, N'Guyen TM, Deelchand D, Rinaldi D, Valabregue R, Wary C, Carlier PG, Durr A, Henry PG.

Mov Disord. 2012 Jun;27(7):907-10. doi: 10.1002/mds.25009.

0

0

0

PUBMED

The Huntington's Disease health-related Quality of Life questionnaire (HDQoL): a disease-specific measure of health-related quality of life.

Hocaoglu MB, Gaffan EA, Ho AK.

Clin Genet. 2012 Feb;81(2):117-22. doi: 10.1111/j.1399-0004.2011.01823.x.

0

0

0

PUBMED

P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.

Fan J, Gladding CM, Wang L, Zhang LY, Kaufman AM, Milnerwood AJ, Raymond LA.

Neurobiol Dis. 2012 Mar;45(3):999-1009. doi: 10.1016/j.nbd.2011.12.019.

0

0

0

PUBMED

Longitudinal analysis of the behavioural phenotype in R6/1 (C57BL/6J) Huntington's disease transgenic mice.

Brooks SP, Janghra N, Workman VL, Bayram-Weston Z, Jones L, Dunnett SB.

Brain Res Bull. 2012 Jun 1;88(2-3):94-103. doi: 10.1016/j.brainresbull.2011.01.010.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy